Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 217-588-1 | CAS number: 1897-45-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 983
- Report date:
- 1981
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- GLP compliance:
- yes
- Type of assay:
- mammalian erythrocyte micronucleus test
Test material
- Reference substance name:
- Chlorothalonil
- EC Number:
- 217-588-1
- EC Name:
- Chlorothalonil
- Cas Number:
- 1897-45-6
- Molecular formula:
- C8Cl4N2
- IUPAC Name:
- tetrachlorobenzene-1,3-dicarbonitrile
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Weight at study initiation: rats of approximately 150 g (males)
- Diet: ad libitum
- Water: ad libitum
- Acclimation: All animals will be held for a minimal period of time to assure that all the animals used for the preliminary or main test are in good health.
- Housing: Currently acceptable practices of good animal husbandry was followed at all times
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- - Vehicle used: 0.5 % (w/w) Methocel E15 Premium (hydroxy-propyl methylcellulose) in ion-exchanged water.
- Amount of vehicle: 2 mL - Details on exposure:
- All the suspensions or solutions were prepared extemporeanously in a solution at 0.5 % methocel. Test substance was crushed in a mortar in small quantities of aqueous solution of methacel. The volume was then adjusted with the same vehicle. The animals were not be fasted prior to the administration of the test material, vehicle or the positive control.
- Duration of treatment / exposure:
- Two days
- Frequency of treatment:
- Two doses with a 24 hours interval in between
- Post exposure period:
- 6 hours
Doses / concentrationsopen allclose all
- Dose / conc.:
- 8 mg/kg bw/day (actual dose received)
- Remarks:
- Group II, suspension at 0.4 mg/mL
- Dose / conc.:
- 40 mg/kg bw/day (actual dose received)
- Remarks:
- Group III, suspension at 2 mg/mL
- Dose / conc.:
- 200 mg/kg bw/day (actual dose received)
- Remarks:
- Group IV, suspension at 10 mg/mL
- Dose / conc.:
- 1 000 mg/kg bw/day (actual dose received)
- Remarks:
- Group V, suspension at 50 mg/mL
- Dose / conc.:
- 5 000 mg/kg bw/day (actual dose received)
- Remarks:
- Group VI, suspension at 250 mg/mL
- No. of animals per sex per dose:
- 10
- Control animals:
- yes, concurrent vehicle
- Positive control(s):
- Substance: Methy methasulfonate (MMS)
Route of administration: oral gavage
Doses: 65 mg/kg, suspended at 2.5 μL/mL (Group VII)
Examinations
- Tissues and cell types examined:
- Polychromatic erythrocytes (PCEs) in bone morrow
- Details of tissue and slide preparation:
- CRITERIA FOR DOSE SELECTION: A preliminary study was conducted to determine the maximum dose of test substance which could be administered by incubation.
METHOD OF ANALYSIS: The principle of the method consists to search the presence of a rest of chromosome in the young erythrocits of the marrow. Clastogenic agents can cause breakdown of a chromosome at the mitosis and the fragment which is not, at the telophase, included in the cell, appears in the cytoplasm as a small ball (from where the name of micronucleus). Micronuclei have been observed on animals treated with agents considered as mutagenic, at the level of different cells of the marrow, namely the myelocyts and the erythroblasts. However, the most are observed in the polychromatophilic erythrocits, cells particularly interesting for this study, because a few hours after the end of their last mitosis, these cells expel their nucleus. This chromosomal rest is easily recognisable. The young erythrocits, less than 24 hours old, have besides, the advantage to possess tinctorial properties different from the adult erythrocits.
The product is administered in two shots at 24 hours interval and the animals are sacrificed 6 hours after the second administration. The femur is taken and cut at its two ends in order to loosen the medular tubular. The marrow is recovered in serum of veal’s embryon. After centrifugation, the bottom is homogenized and one drop is laid out on a lamina. The smear is dried and coloured by the May Grünwald-Giemsa. The counting of the cells carrying micronuclei is realized on 2000 polychromatophilic erythrocits. The readings are done by two observers which read each on a different lamina 1000 polychromatophilic erythrocits. The average of these two reading is then calculated. - Statistics:
- The statistical analysis consisted by a comparison of two measures done with the Student’s method, valid for small samples. The value of t calculated has been compared to the value of t theoric given in a distribution table of t.
Results and discussion
Test results
- Key result
- Sex:
- male
- Genotoxicity:
- negative
- Toxicity:
- yes
- Remarks:
- One animal died approximately 4 hours after the second administration.
- Vehicle controls validity:
- valid
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- RESULTS OF RANGE-FINDING STUDY
- In the preliminary study four rats were orally dosed with 5000 mg/kg test substance. The rats were dosed twice with a 25 hour interval between doses. One rat died before the second dosing, the other three animals survived at least six hours after the second dose. The maximum dose selected for the micronucleus test was set at 5000 mg/kg.
MICRONUCLEUS TEST
- Dose levels for the micronucleus test in the rat were 0, 8, 40, 200, 1000 and 5000 mg/kg. Ten males rats per group were dosed twice with a 24 hour interval between doses. One high dose rat died four hours after the second administration of test material and was not included in the micronuclei evaluation. The mean per cent polychromatic erythrocytes with micronuclei did not differ statistically from the vehicle control. The mean per cent polychromatic erythrocytes with micronuclei from rats treated with MMS was statistically higher than controls.
Any other information on results incl. tables
Table 1: Polychomatophilic erythrocits average (P.E.) carying micrnuclei in rats
Products |
Doses mg/kg (PO) |
Number of animals |
% of P.E. with micronuclei m -/+ 2 Sm |
Control methocel |
|
10 |
0.16 ± 0.08 |
Test substance |
2 x 8 |
10 |
0.21 ± 0.06 |
2 x 40 |
10 |
0.22 ± 0.04 |
|
2 x 200 |
10 |
0.17 ± 0.07 |
|
2 x 1000 |
10 |
0.23 ± 0.04 |
|
2 x 5000 |
9 |
0.23 ± 0.06 |
|
MMS |
2 x 65 |
10 |
3.22 ± 1.10 |
Applicant's summary and conclusion
- Conclusions:
- Orally administered test substance to male rats at 2 x 8, 2 x 40, 2 x 200, 2x 1000 and 2 x 5000 mg/kg has not determined at the level of the marrow any increasing of the average of polychromatophilic erythrocits carrying micronuclei (Schmid’s micronuclei technic). By the same way methylmethanesulfonate utilised as positive control at the dose of 2 x 65 mg/kg appeared as a clastogenic agent. The absence of clastogenic property of the test substance indicates then, according to the interpretation admitted by the technic applied, an absence of mutagenic effect.
- Executive summary:
An OECD 474 -like micronucleus test in compliance with GLP was conducted in rats to determine if the substance, orally administered, caused formation of micronuclei in polychromatic erythrocytes. Only male animals were used for the tests. Animals were given two doses of substance by gavage with a 24 hour interval between doses. Polychromatic erythrocytes in the bone marrow were evaluated for the presence of micronuclei. Oral administration of test substance to rats did not cause an increased incidence of micronuclei in polychromatophilic erythrocytes in the bone marrow of these animals.
A possible Mutagenic potentiality has been searched for by the technic of Micronucleus in Rat. Suspension of test substance in an aqueous solution at 0.5 % of methocel has been orally administered in two shots at 24 hours interval to groups of 9 or 10 males rats, 8, 40, 200, 1000 or 5000 mg/kg/day. The animals were sacrificed by cervical dislocation 6 hours after the second shot. Hematogenic marrow smears taken from the femur, were prepared. The polychromatophilic erythrocits count which carry micronuclei was done on 2000 elements per animal, by two observers which read each 1000 elements.
The administration of test substance has not induced any significant increasing of the polychromatophilic erythrocits average carrying micronuclei; an increasing should have indicated a clastogenic effect of the product. On the other hand, methyl-methanesulfonate, utilised as positive control and orally administered at 65 mg/kg/day, increases the polychromatophilic erythrocits average with micronuclei. In conclusion, the absence of the clastogenic effect of test substance expresses, according to the interpretation of the technic utilized, the absence of Mutagenic effect.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.